Follow The Filings

JAZZ Jazz Pharmaceuticals

Jazz Pharmaceuticals earnings company data as of 4:45 AM ET 11/1

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 2 Nov EPS 1.97 — —
Rev $1.21B — —

Insider trades

Open-market buys and sales by JAZZ's executives, directors and 10% owners in the last 12 months, from their Form 4s

All JAZZ insider trades
  • None no insider bought on the open market
  • $35.3M sold by 8 insiders outside a trading plan
  • $33.2M sold by 5 insiders under 10b5-1 plans
  1. Renee D Gala CEO
    Planned sale
    $473K 2,000 shares at $236.40 1.4% of stake
    Traded Oct 6 Filed Oct 7
  2. Bruce C Cozadd Director
    Planned sale
    $1.4M 6,000 shares at $230.33 1.7% of stake
    Traded Oct 1 Filed Oct 5
  3. Neena M Patil EVP & Chief Legal Officer
    Planned sale
    $289K 1,200 shares at $240.94 2.5% of stake
    Traded Sep 10 Filed Sep 14
  4. Renee D Gala CEO
    Planned sale
    $486K 2,000 shares at $243.03 1.4% of stake
    Traded Sep 8 Filed Sep 10
  5. Bruce C Cozadd Director
    Planned sale
    $1.5M 6,000 shares at $250.13 1.7% of stake
    Traded Sep 1 Filed Sep 2
  6. Robert Iannone EVP, Global Head of R&D & CMO
    Planned sale
    $19.2M 76,921 shares at $249.70 54% of stake
    Traded Aug 27 Filed Aug 31
  7. Bruce C Cozadd Director
    Planned sale
    $1.5M 6,000 shares at $252.98 1.6% of stake
    Traded Aug 3 Filed Aug 5
  8. Bruce C Cozadd Director
    Planned sale
    $1.4M 6,000 shares at $240.47 1.6% of stake
    Traded Jul 1 Filed Jul 6
  9. Mark Douglas Smith Director
    Planned sale
    $267K 1,157 shares at $230.55 11% of stake
    Traded Jun 15 Filed Jun 17
  10. Neena M Patil EVP & Chief Legal Officer
    Planned sale
    $278K 1,200 shares at $231.83 2.3% of stake
    Traded Jun 10 Filed Jun 12
  11. Bruce C Cozadd Director
    Planned sale
    $1.4M 6,000 shares at $235.12 1.6% of stake
    Traded Jun 1 Filed Jun 3
  12. Samantha Pearce EVP, Chief Commercial Officer
    Sale
    $1.6M 6,907 shares at $235.41 12% of stake
    Traded May 28 Filed Jun 1
  13. Neena M Patil EVP & Chief Legal Officer
    Planned sale
    $282K 1,192 shares at $236.97 2.2% of stake
    Traded May 28 Filed Jun 1
  14. Heather Ann McSharry Director
    Sale
    $482K 2,000 shares at $241.00 9.8% of stake
    Traded May 22 Filed May 27
  15. Rick E Winningham Director
    Sale
    $662K 2,741 shares at $241.57 22% of stake
    Traded May 22 Filed May 27

Also filed in the last 12 months, not counted as buying or selling: 45 share withholdings for taxes, 27 stock grants, 17 option exercises, 2 sales back to the company, 2 sales to cover taxes, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 10 shown.

Filed Form Detail Links
8-K 2.02
8-K 5.02
8-K 1.01,2.03,9.01
8-K 7.01
8-K 1.01,2.03,3.02,8.01,9.01
8-K 8.01
8-K 7.01,9.01
8-K 1.01,9.01
SCHEDULE 13G —
10-Q

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.